Durability of efficacy and safety with selpercatinib in patients (pts) with RET fusion+ non-small cell lung cancer (NSCLC) Meeting Abstract


Authors: Drilon, A.; Subbiah, V.; Gautschi, O.; Tomasini, P.; De Braud, F. G. M.; Solomon, B.; Tan, D. S. W.; Alonso, G.; Wolf, J.; Park, K.; Goto, K.; Soldatenkova, V.; Szymczak, S.; Barker, S.; Puri, T.; Lin, A. B.; Loong, H. H. F.; Besse, B.
Abstract Title: Durability of efficacy and safety with selpercatinib in patients (pts) with RET fusion+ non-small cell lung cancer (NSCLC)
Meeting Title: European Lung Cancer Congress (ELCC) 2022
Journal Title: Annals of Oncology
Volume: 33
Issue: Suppl. 2
Meeting Dates: 2022 Mar 30-Apr 2
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2022-04-01
Start Page: S43
Language: English
ACCESSION: WOS:000778453100028
DOI: 10.1016/j.annonc.2022.02.036
PROVIDER: wos
Notes: Meeting Abstract: 27P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon